Related references
Note: Only part of the references are listed.Predictors of Progression in Barrett's Esophagus: Current Knowledge and Future Directions
Ganapathy A. Prasad et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma
B. P. L. Wijnhoven et al.
BRITISH JOURNAL OF SURGERY (2010)
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
Mayuko Furuta et al.
CARCINOGENESIS (2010)
MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
Mael Chalret du Rieu et al.
CLINICAL CHEMISTRY (2010)
Robust MicroRNA Stability in Degraded RNA Preparations from Human Tissue and Cell Samples
Monika Jung et al.
CLINICAL CHEMISTRY (2010)
Greater lnterobserver Agreement by Endoscopic Mucosal Resection Than Biopsy Samples in Barrett's Dysplasia
Sachin Wani et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma
Ji Kon Ryu et al.
PANCREATOLOGY (2010)
MicroRNA-196a Is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus
Dipen M. Maru et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells
Hongping Xia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
MicroRNA Expression Signatures in Barrett's Esophagus and Esophageal Adenocarcinoma
Hushan Yang et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
Ewy A. Mathe et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma
Takatsugu Kan et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
MicroRNAs: Key Modulators of Posttranscriptional Gene Expression
Steven P. O'Hara et al.
GASTROENTEROLOGY (2009)
The miR-106b-25 Polycistron, Activated by Genomic Amplification, Functions as an Oncogene by Suppressing p21 and Bim
Takatsugu Kan et al.
GASTROENTEROLOGY (2009)
MicroRNAs in clinical oncology: at the crossroads between promises and problems
S. M. Metias et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
MicroRNA-143 and-205 Expression in Neosquamous Esophageal Epithelium Following Argon Plasma Ablation of Barrett's Esophagus
Willem A. Dijckmeester et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Barrett's Esophagus
Prateek Sharma
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Micromanaging Cancer
Judy Lieberman
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray
Michael J. Lodes et al.
PLOS ONE (2009)
Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
Roy Navon et al.
PLOS ONE (2009)
Molecular Markers and Genetics in Cancer Development
Kathy Hormi-Carver et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Hormonal Regulation of MicroRNA Expression in Periovulatory Mouse Mural Granulosa Cells
Stephanie D. Fiedler et al.
BIOLOGY OF REPRODUCTION (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling
Anna E. Szafranska et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
MicroRNA expression profiles of esophageal cancer
Andrew Feber et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance
Pierre Lao-Sirieix et al.
CLINICAL CANCER RESEARCH (2007)
The development and validation of an endoscopic grading system for Barrett's esophagus: The Prague C & M Criteria
Prateek Sharma et al.
GASTROENTEROLOGY (2006)
TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohort
L. Murray et al.
GUT (2006)
Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus
Prateek Sharma et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma
J Brabender et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Molecular cytogenetics in haematological malignancy: current technology and future prospects
L Kearney et al.
CHROMOSOMA (2005)
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence
H Pohl et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation
E Montgomery et al.
HUMAN PATHOLOGY (2001)
Share Paper
